104 related articles for article (PubMed ID: 19822511)
1. Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis.
Lu AT; Salpeter SR; Reeve AE; Eschrich S; Johnston PG; Barrier AJ; Bertucci F; Buckley NS; Salpeter EE; Lin AY
Clin Colorectal Cancer; 2009 Oct; 8(4):207-14. PubMed ID: 19822511
[TBL] [Abstract][Full Text] [Related]
2. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of clinically available gene expression profiling assays for stage II colorectal cancer: initial steps toward genetic staging.
Lopez NE; Weiss AC; Robles J; Fanta P; Ramamoorthy SL
Am J Surg; 2016 Oct; 212(4):700-714. PubMed ID: 27637150
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
5. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
6. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.
Nguyen MN; Choi TG; Nguyen DT; Kim JH; Jo YH; Shahid M; Akter S; Aryal SN; Yoo JY; Ahn YJ; Cho KM; Lee JS; Choe W; Kang I; Ha J; Kim SS
Oncotarget; 2015 Oct; 6(31):31674-92. PubMed ID: 26397224
[TBL] [Abstract][Full Text] [Related]
7. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
Wu D; Li Q; Song G; Lu J
J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Sabarimurugan S; Madhav MR; Kumarasamy C; Gupta A; Baxi S; Krishnan S; Jayaraj R
Mol Diagn Ther; 2020 Feb; 24(1):15-30. PubMed ID: 32020560
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL
Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
[TBL] [Abstract][Full Text] [Related]
11. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
[TBL] [Abstract][Full Text] [Related]
14. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S
Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138
[TBL] [Abstract][Full Text] [Related]
15. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.
Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F
EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.
Sanz-Pamplona R; Berenguer A; Cordero D; Riccadonna S; Solé X; Crous-Bou M; Guinó E; Sanjuan X; Biondo S; Soriano A; Jurman G; Capella G; Furlanello C; Moreno V
PLoS One; 2012; 7(11):e48877. PubMed ID: 23145004
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis.
Wei HT; Guo EN; Dong BG; Chen LS
BMC Gastroenterol; 2015 Oct; 15():152. PubMed ID: 26518017
[TBL] [Abstract][Full Text] [Related]
18. Gene signatures of estrogen and progesterone receptor pathways predict the prognosis of colorectal cancer.
Liu D
FEBS J; 2016 Aug; 283(16):3115-33. PubMed ID: 27376509
[TBL] [Abstract][Full Text] [Related]
19. Stage-specific frequency and prognostic significance of aneuploidy in patients with sporadic colorectal cancer--a meta-analysis and current overview.
Laubert T; Freitag-Wolf S; Linnebacher M; König A; Vollmar B; Habermann JK;
Int J Colorectal Dis; 2015 Aug; 30(8):1015-28. PubMed ID: 26054386
[TBL] [Abstract][Full Text] [Related]
20. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Perakis SO; Thomas JE; Pichler M
Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]